Here are the recap for the top 4 major losers in the small-cap biotech sector on Tuesday. keep an eye on the following stocks this week.
Mereo BioPharma Group plc (NASDAQ:MREO) was one of the major losers as the stock closed lower by $0.23 or 6.61% to close at $3.25. Last week, the company announced positive data from an interim analysis of an investigator-initiated study of alvelestat in patients with Bronchiolitis Obliterans Syndrome (“BOS”) following hematopoietic stem cell transplantation (“HCT”).
MacroGenics, Inc. (NASDAQ:MGNX) continued to move lower and closed lower by 4.15% to $22.64 on the volume of 1.45 million shares, compared to its daily average volume of 751K shares. Stock declined more than 28% in the last one month of trading sessions.
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) stock jumped by $0.18 or 4.63% to end the session at $3.71. After opening at $3.595, the stock has moved within a wide range of $3.46 – $3.85. The stock has jumped more than 900% in the last one year of trading sessions.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) was one of the major losers as the stock closed lower by $3.62 or 16.18% to close at $18.76. Total volume was 2.35 million shares, compared to its 30-day average volume of 599K shares. The stock moved within a range of $18.42 – $23.98 after opening at $23.50.
